[Efficacy and immune memory of plasma-derived hepatitis B vaccine 11 years after primary immunization]

Zhonghua Yu Fang Yi Xue Za Zhi. 2000 Mar;34(2):113-5.
[Article in Chinese]

Abstract

Objective: To evaluate the long-term efficacy of hepatitis B vaccine 10 years after primary immunization to provide scientific basis for the time of revaccination.

Methods: The study was strictly designed with randomization, double-blinding, and placebo-controlled method to observe the efficacy and immune memory 11 years following hepatitis B vaccination.

Results: Immunogenicity and protective rate of vaccine were still kept well 11 years after immunization with a protective rate against HBV infection of 73.5%. But, there was no significant difference in HBV infection rates between vaccine group and placebo-controlled group (7.89% vs. 13.25%, P > 0.1) nine to 11 years following immunization. There still existed immune memory 11 years after immunization, but it was significantly weaker than that within the first 10 years after immunization.

Conclusion: The efficacy of the vaccine had begun to drop 11 years after immunization, which should be followed up further to reach a clear conclusion.

Publication types

  • Clinical Trial
  • English Abstract
  • Randomized Controlled Trial

MeSH terms

  • Double-Blind Method
  • Follow-Up Studies
  • Hepatitis B / prevention & control*
  • Hepatitis B Antibodies / blood
  • Hepatitis B Core Antigens / blood
  • Hepatitis B Surface Antigens / blood
  • Hepatitis B Vaccines / immunology*
  • Humans
  • Time Factors
  • Vaccination*

Substances

  • Hepatitis B Antibodies
  • Hepatitis B Core Antigens
  • Hepatitis B Surface Antigens
  • Hepatitis B Vaccines